好评率
100%
  • Pan M; Luo M; Liu L, et al., EGR1 suppresses HCC growth and aerobic glycolysis by transcriptionally downregulating PFKL. J Exp Clin Cancer Res 2024, 43 (1), 35.
    IF: 11.3
    Year: 2024 Journal: J Exp Clin Canc Res
    PubMed: 38287371
  • Zhang W; Wang Q; Xing X, et al., The antagonistic effects and mechanisms of microRNA-26a action in hypertensive vascular remodelling. Br J Pharmacol 2021, 178 (5), 1037-1054.
    IF: 7.73
    Year: 2020 Journal: Br J Pharmacol
    PubMed: 33305374
  • Zhang X; Liu L; Liu X, et al., Chidamide suppresses adipogenic differentiation of bone marrow derived mesenchymal stem cells via increasing REEP2 expression. iScience 2023, 26 (3), 106221.
    IF: 6.107
    Year: 2023 Journal: iScience
    PubMed: 36879811
  • Yu S; Yang J; Zhang R, et al., SLC15A3 is transcriptionally regulated by HIF1α and p65 to worsen neuroinflammation in experimental ischemic stroke. Molecular Neurobiology 2024, 1-16.
    IF: 5.1
    Year: 2024 Journal: Mol Neurobiol
    PubMed: 38717559
  • Wang B; Fan X; Wang L, et al., The RNA-binding protein sorbin and SH3 domain-containing 2 are transcriptionally regulated by specificity protein 1 and function as tumor suppressors in bladder cancer by stabilizing tissue factor pathway inhibitor. Mol Carcinog 2024.
    IF: 4.6
    Year: 2024 Journal: Mol Carcinog
    PubMed: 38501385
  • Cao Q; Wang X; Liu J, et al., ICBP90, an epigenetic regulator, induces DKK3 promoter methylation, promotes glioma progression, and reduces sensitivity to cis-platinum. Exp Cell Res 2024, 113976.
    IF: 3.7
    Year: 2024 Journal: Exp Cell Res
    PubMed: 38401687
  • Shen H; Nie J; Wang X, et al., MOTS-c relieves hepatocellular carcinoma resistance to TRAIL-induced apoptosis under hypoxic conditions by activating MEF2A. Exp Cell Res 2025, 444 (1), 114354.
    IF: 3.3
    Year: 2024 Journal: Exp Cell Res
    PubMed: 39581216
  • Feng H; Liu J; Jia H, et al., Cancer-associated fibroblasts-derived exosomal ZNF250 promotes the proliferation, migration, invasion, and immune escape of hepatocellular carcinoma cells by transcriptionally activating PD-L1. J Biochem Mol Toxicol 2024, 38 (9), e23778.
    IF: 3.2
    Year: 2024 Journal: J Biochem Mol Toxicol
    PubMed: 39252517
0
产品咨询微信

服务热线

400-602-0407

APP下载
生物狗小程序